Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.
3 published notice versions reviewed by ProcuraAxis.
3 VERSIONS
1
023698-2026Pipeline notice on Find a Tender ·
2
083668-2026Preliminary market engagement notice on Find a Tender ·
3
094856-2026Tender notice on Find a Tender ·
PROCURAAXIS ANALYSIS
ProcuraAxis Analysis
Our approved analysis of the opportunity appears below the official tender information.
ANALYSIS PREVIEW
Opportunity intelligence at a glance
Open tender for supplying antiviral medicines used to treat Hepatitis C (HCV) to NHS Wales. The stated deadline is 6 November 2026 at 12:00 UTC.
Who this may suit
Suitable for suppliers able to provide Hepatitis C antiviral pharmaceutical products to NHS Wales. Detailed technical, quality, supplier-selection and contractual requirements are not supplied.
Key points identified
Required supplyAntiviral medicines for treatment of Hepatitis C (HCV)Evidence: "This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales."
Detailed technical and quality requirementsUnknownEvidence: No tender specification or supporting tender documents were supplied.
Supplier eligibility criteriaUnknownEvidence: No selection or exclusion criteria were supplied.
91% approved-analysis confidence5 supplier criteria identified3 risks or unknowns
ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.
Open tender for supplying antiviral medicines used to treat Hepatitis C (HCV) to NHS Wales. The stated deadline is 6 November 2026 at 12:00 UTC.
Who this may suit
Suitable for suppliers able to provide Hepatitis C antiviral pharmaceutical products to NHS Wales. Detailed technical, quality, supplier-selection and contractual requirements are not supplied.
Key deliverables
Antiviral medicines for treatment of Hepatitis C (HCV)
Supply to NHS Wales
SUPPLIER REQUIREMENTS
5 criteria identified
Required supply
99% confidence
Antiviral medicines for treatment of Hepatitis C (HCV)
View supporting evidence
"This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales."
Detailed technical and quality requirements
99% confidence
Unknown
View supporting evidence
No tender specification or supporting tender documents were supplied.
Supplier eligibility criteria
99% confidence
Unknown
View supporting evidence
No selection or exclusion criteria were supplied.
SME suitability
99% confidence
Unknown
View supporting evidence
The opportunity data does not state whether the tender is suitable for SMEs.
VCSE suitability
99% confidence
Unknown
View supporting evidence
The opportunity data does not state whether the tender is suitable for VCSEs.
COMMERCIAL AND DELIVERY
Contract intelligence
Commercial
Stated maximum value
96% confidence
GBP 6,549,650.36
View supporting evidence
Opportunity value_max is 6549650.36 GBP; Lot 1 value is 6549650.36 GBP.
Contract term
99% confidence
Unknown
View supporting evidence
Contract start and end dates were not supplied.
Pricing and payment terms
99% confidence
Unknown
View supporting evidence
No commercial terms or tender documents were supplied.
Delivery
Customer
99% confidence
NHS Wales
View supporting evidence
The description states that medicines are to be provided "to NHS Wales."
Delivery geography
95% confidence
Wales (UKL)
View supporting evidence
The supplied delivery location is region UKL, United Kingdom.
Delivery schedule and logistics requirements
99% confidence
Unknown
View supporting evidence
No delivery schedule, volumes or logistics requirements were supplied.
PROCEDURE
How to respond
Procedure
99% confidence
Open procedure
View supporting evidence
procurement_method_details is "Open procedure".
Opportunity status
99% confidence
Open
View supporting evidence
display_status is "open" and source_status is "active".
Submission deadline
99% confidence
6 November 2026, 12:00 UTC
View supporting evidence
submission_deadline is 2026-11-06T12:00:00+00:00; the same deadline is recorded for Lot 1.
Lots
98% confidence
One active lot (Lot 1)
View supporting evidence
The supplied lot data contains one active lot, identified as "1".
RISKS AND UNKNOWNS
Points requiring attention
Specification and award-criteria risk
99% confidence
Technical specification, quality requirements, evaluation criteria and tender documents are not supplied.
View supporting evidence
Only the tender notice metadata and high-level description were supplied.
Supply-chain and delivery risk
99% confidence
Required medicine volumes, delivery cadence, storage requirements and distribution arrangements are unknown.
View supporting evidence
No delivery or logistics detail is present in the supplied data.
Commercial risk
99% confidence
Contract duration, pricing mechanism and payment terms are unknown.
View supporting evidence
No contract dates or detailed commercial terms were supplied.
ProcuraAxis analysis supplements, but does not replace, the original notice and tender documents. Always verify eligibility, deadlines and commercial terms with the issuing authority.
Continue in your ProcuraAxis workspaceFree account · Full approved analysis